NCT01941680View on ClinicalTrials.gov

High Risk Adult T-cell Leukemia/Lymphoma (ATLL-HR) and Allogeneic Transplant

CompletedOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

February 28, 2018

Study Completion Date

March 31, 2021

Conditions
T-cell LymphomaLeukaemia
Trial Locations (2)

Unknown

CHU Pinteà Pitre/Abymes, Pointe-à-Pitre

CHU de Martinique, Fort-de-France

All Listed Sponsors
lead

University Hospital Center of Martinique

OTHER

NCT01941680 - High Risk Adult T-cell Leukemia/Lymphoma (ATLL-HR) and Allogeneic Transplant | Biotech Hunter | Biotech Hunter